Privolzhsky Research Medical University is one of the medical schools in the Russian Federation which is located in the city of Nizhny Novgorod.

During the past decade, Privolzhsky District Medical Centre conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Privolzhsky District Medical Centre" are "Colitis, Ulcerative" (2 trials), "Crohn Disease" (1 trials), "Crohn's Disease (CD)" (1 trials), "Metastatic Castrate Sensitive Prostate Cancer" (1 trials) and "Metastatic Prostate Cancer" (1 trials). Many other conditions were trialed in "Privolzhsky District Medical Centre" in a lesser frequency.

Most popular intervention types in "Privolzhsky District Medical Centre" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone acetate (AA)" (1 trials), "Apixaban 2.5 mg" (1 trials), "Apixaban placebo" (1 trials), "Carboplatin" (1 trials) and "Cetrelimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Privolzhsky District Medical Centre" are 7 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Privolzhsky District Medical Centre". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Privolzhsky District Medical Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Privolzhsky District Medical Centre, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".